Dernière minute
KR중기부, 2026년 하반기 혁신제품 신규 지정 접수 시작INतुर्की को एफ़-35 देने की तैयारी में ट्रंप पर इसराइल बोला ये नहीं होना चाहिए, जानिए क्या है उसका डरKR'성희롱 시정권고 사례집' 발간…'2차 피해' 호소 늘어DETrump bezeichnet sich selbst als "größten Kommunisten der Geschichte"RUЭксперт: Ставки по автокредитам в 2025-2026 годах будут снижаться плавнее ключевой ставкиVNJustin Bieber sẽ diễn giữa hiệp chung kết World CupKR8 industrial software sellers fined 2.37 billion won for price-fixing and market divisionRUULA исчерпала ракеты Atlas V с российскими двигателями для других запусковKR대통령기록관, 제15회 인구의 날 맞아 관련 기록물 41건 공개ARNothing Phone (4b) يظهر بمواصفات قوية ومقاومة للماء والغبارKR중기부, 2026년 하반기 혁신제품 신규 지정 접수 시작INतुर्की को एफ़-35 देने की तैयारी में ट्रंप पर इसराइल बोला ये नहीं होना चाहिए, जानिए क्या है उसका डरKR'성희롱 시정권고 사례집' 발간…'2차 피해' 호소 늘어DETrump bezeichnet sich selbst als "größten Kommunisten der Geschichte"RUЭксперт: Ставки по автокредитам в 2025-2026 годах будут снижаться плавнее ключевой ставкиVNJustin Bieber sẽ diễn giữa hiệp chung kết World CupKR8 industrial software sellers fined 2.37 billion won for price-fixing and market divisionRUULA исчерпала ракеты Atlas V с российскими двигателями для других запусковKR대통령기록관, 제15회 인구의 날 맞아 관련 기록물 41건 공개ARNothing Phone (4b) يظهر بمواصفات قوية ومقاومة للماء والغبار
Newsgather
BackWockhardt's Antibiotic Zaynich Gets US FDA Approval for Complicated UTIs
Wockhardt's Antibiotic Zaynich Gets US FDA Approval for Complicated UTIs
Santé
Economic Times30.05.2026SantéIndia

Wockhardt's Antibiotic Zaynich Gets US FDA Approval for Complicated UTIs

Breakthrough Drug Targets Superbugs, Also Approved in India for UTIs and Bacteremia

L'essentiel

  • Wockhardt's novel antibiotic Zaynich (cefepime and zidebactam) has received US FDA approval for treating complicated urinary tract infections (UTIs), including pyelonephritis, caused by resistant microorganisms.
  • It also gained approval in India for UTIs and concurrent Gram-negative bacteremia, addressing the growing antimicrobial resistance threat.

Résumé généré par IA

Taille de police

Wockhardt's novel antibiotic Zaynich (cefepime and zidebactam) has received US FDA approval for treating complicated urinary tract infections (UTIs), including pyelonephritis, caused by resistant microorganisms. It also gained approval in India for UTIs and concurrent Gram-negative bacteremia, addressing the growing antimicrobial resistance threat.

Read the full article on Economic Times

Sujets liés

This article was originally published by Economic Times.

Articles liés

Plus sur ce sujetZaynich